ID

36289

Beschreibung

Hepatitis B Virus Reactivation After Withdrawal of Preemptive Antiviral Therapy in Hematologic Malignancy; ODM derived from: https://clinicaltrials.gov/show/NCT02056548

Link

https://clinicaltrials.gov/show/NCT02056548

Stichworte

  1. 30.04.19 30.04.19 -
  2. 20.09.21 20.09.21 -
Rechteinhaber

See clinicaltrials.gov

Hochgeladen am

30. April 2019

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Lymphoma NCT02056548

Eligibility Lymphoma NCT02056548

  1. StudyEvent: Eligibility
    1. Eligibility Lymphoma NCT02056548
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
18 years old or older
Beschreibung

Age

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
ecog performance status 0, 1, 2
Beschreibung

ECOG performance status

Datentyp

boolean

Alias
UMLS CUI [1]
C1520224
hodgkin's or non-hodgkins lymphomas according to the who 2008 classification
Beschreibung

Hodgkin Lymphoma WHO tumor classification | Non-Hodgkin Lymphoma WHO tumor classification

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0019829
UMLS CUI [1,2]
C1301142
UMLS CUI [2,1]
C0024305
UMLS CUI [2,2]
C1301142
patients who received standard cytotoxic chemotherapies
Beschreibung

Cytotoxic Chemotherapy Standard

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0677881
UMLS CUI [1,2]
C1442989
patients who finished chemotherapy (duration not exceeded 6 months) or who will finish the planned chemotherapy
Beschreibung

Chemotherapy Discontinued | Chemotherapy Planned To be stopped

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C1444662
UMLS CUI [2,1]
C0392920
UMLS CUI [2,2]
C1301732
UMLS CUI [2,3]
C1272691
patients who achieved at least partial response and do not need further chemotherapy
Beschreibung

Partial response | Response | Chemotherapy Discontinued

Datentyp

boolean

Alias
UMLS CUI [1]
C1521726
UMLS CUI [2]
C1704632
UMLS CUI [3,1]
C0392920
UMLS CUI [3,2]
C1444662
hbsag (+) patients who received preemptive antiviral therapies
Beschreibung

Hepatitis B surface antigen positive | Antiviral Therapy

Datentyp

boolean

Alias
UMLS CUI [1]
C0149709
UMLS CUI [2]
C0280274
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
anti-hcv ab(+), hiv(+), or autoimmune hepatitis
Beschreibung

Hepatitis C antibody positive | HIV Seropositivity | Hepatitis, Autoimmune

Datentyp

boolean

Alias
UMLS CUI [1]
C0281863
UMLS CUI [2]
C0019699
UMLS CUI [3]
C0241910
complications due to uncompensated liver cirrhosis
Beschreibung

Complications Due to Liver Cirrhosis Uncompensated

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0009566
UMLS CUI [1,2]
C0678226
UMLS CUI [1,3]
C0023890
UMLS CUI [1,4]
C0205433
child pugh score : 10 points or more
Beschreibung

Child-Pugh Classification

Datentyp

boolean

Alias
UMLS CUI [1]
C2347612
hepatocellular carcinoma
Beschreibung

Liver carcinoma

Datentyp

boolean

Alias
UMLS CUI [1]
C2239176
patients who finish the lymphoma treatments with only radiotherapy
Beschreibung

Therapeutic radiology procedure Discontinued Lymphoma

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1522449
UMLS CUI [1,2]
C1444662
UMLS CUI [1,3]
C0024299

Ähnliche Modelle

Eligibility Lymphoma NCT02056548

  1. StudyEvent: Eligibility
    1. Eligibility Lymphoma NCT02056548
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
18 years old or older
boolean
C0001779 (UMLS CUI [1])
ECOG performance status
Item
ecog performance status 0, 1, 2
boolean
C1520224 (UMLS CUI [1])
Hodgkin Lymphoma WHO tumor classification | Non-Hodgkin Lymphoma WHO tumor classification
Item
hodgkin's or non-hodgkins lymphomas according to the who 2008 classification
boolean
C0019829 (UMLS CUI [1,1])
C1301142 (UMLS CUI [1,2])
C0024305 (UMLS CUI [2,1])
C1301142 (UMLS CUI [2,2])
Cytotoxic Chemotherapy Standard
Item
patients who received standard cytotoxic chemotherapies
boolean
C0677881 (UMLS CUI [1,1])
C1442989 (UMLS CUI [1,2])
Chemotherapy Discontinued | Chemotherapy Planned To be stopped
Item
patients who finished chemotherapy (duration not exceeded 6 months) or who will finish the planned chemotherapy
boolean
C0392920 (UMLS CUI [1,1])
C1444662 (UMLS CUI [1,2])
C0392920 (UMLS CUI [2,1])
C1301732 (UMLS CUI [2,2])
C1272691 (UMLS CUI [2,3])
Partial response | Response | Chemotherapy Discontinued
Item
patients who achieved at least partial response and do not need further chemotherapy
boolean
C1521726 (UMLS CUI [1])
C1704632 (UMLS CUI [2])
C0392920 (UMLS CUI [3,1])
C1444662 (UMLS CUI [3,2])
Hepatitis B surface antigen positive | Antiviral Therapy
Item
hbsag (+) patients who received preemptive antiviral therapies
boolean
C0149709 (UMLS CUI [1])
C0280274 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
Hepatitis C antibody positive | HIV Seropositivity | Hepatitis, Autoimmune
Item
anti-hcv ab(+), hiv(+), or autoimmune hepatitis
boolean
C0281863 (UMLS CUI [1])
C0019699 (UMLS CUI [2])
C0241910 (UMLS CUI [3])
Complications Due to Liver Cirrhosis Uncompensated
Item
complications due to uncompensated liver cirrhosis
boolean
C0009566 (UMLS CUI [1,1])
C0678226 (UMLS CUI [1,2])
C0023890 (UMLS CUI [1,3])
C0205433 (UMLS CUI [1,4])
Child-Pugh Classification
Item
child pugh score : 10 points or more
boolean
C2347612 (UMLS CUI [1])
Liver carcinoma
Item
hepatocellular carcinoma
boolean
C2239176 (UMLS CUI [1])
Therapeutic radiology procedure Discontinued Lymphoma
Item
patients who finish the lymphoma treatments with only radiotherapy
boolean
C1522449 (UMLS CUI [1,1])
C1444662 (UMLS CUI [1,2])
C0024299 (UMLS CUI [1,3])

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video